Risk Benefit Assessment of foods: Key findings from an international workshop by Pires, Sara Monteiro et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Oct 23, 2019
Risk Benefit Assessment of foods: Key findings from an international workshop
Pires, Sara Monteiro; Boué, Géraldine; Boobis, Alan; Eneroth, Hanna; Hoekstra, Jeljer; Membré, Jeanne-
Marie; Persson, Inez Maria; Poulsen, Morten; Ruzante, Juliana; van Klaveren, Jacob
Published in:
Food Research International
Link to article, DOI:
10.1016/j.foodres.2018.09.021
Publication date:
2019
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
Pires, S. M., Boué, G., Boobis, A., Eneroth, H., Hoekstra, J., Membré, J-M., ... Nauta, M. (2019). Risk Benefit
Assessment of foods: Key findings from an international workshop. Food Research International, 116, 859-869.
https://doi.org/10.1016/j.foodres.2018.09.021
 1 
 
Risk Benefit Assessment of foods: key findings from an international workshop 1 
Sara M. Pires1, Géraldine Boué2, Alan Boobis3, Hanna Eneroth4, Jeljer Hoekstra5, 2 
Jeanne-Marie Membré2, Inez Maria Persson1, Morten Poulsen1, Juliana Ruzante6, Jacob 3 
van Klaveren1,5, Sofie T. Thomsen1,  Maarten J. Nauta1  4 
1Division of Diet, Disease Prevention and Toxicology, National Food Institute, Technical University of 5 
Denmark, Lyngby, Denmark 6 
2SECALIM, INRA, Oniris, Université Bretagne Loire, Nantes, France 7 
3Faculty of Medicine, Department of Medicine, Imperial College London, United Kingdom 8 
4Department of Risk Benefit Assessment, the National Food Agency, Uppsala, Sweden 9 
5National Institute for Public Health and the Environment, Bilthoven, The Netherlands  10 
6RTI International, Research Triangle Park, North Carolina, United States 11 
 12 
Corresponding author 13 
Sara Monteiro Pires, DVM, PhD 14 
Division of Diet, Disease prevention and Toxicology, National Food Institute, Technical University of 15 
Denmark. Kemitorvet, building 201. 2800 Kgs. Lyngby 16 
Telephone: +45 40213489; Email: smpi@food.dtu.dk 17 
 2 
 
Keywords: risk-benefit assessment, food safety, nutrition, diet, evidence-based, health impact, food 18 
policy 19 
  20 
 3 
 
Abstract  21 
Whilst risk management measures, including food policy, are developed for the protection of public health and 22 
the environment, they may also lead to a reduction in health benefits. Policy decisions require then 23 
consideration of these necessary trade-offs, which leads to an increasing need to apply formal risk-benefit 24 
assessment (RBA) of foods. In this context, the European Food Safety Authority sponsored a Risk-Benefit 25 
Assessment Workshop on “past, current and future developments within the risk-benefit assessment of foods 26 
(RBA)” held in May 2017. The overall aims of the RBA Workshop were to discuss existing methods, challenges 27 
and needs within RBA, and to draft a roadmap for future development of RBA. The specific objectives were to i) 28 
identify RBA activities in Europe and globally; ii) discuss how to further develop and optimize RBA 29 
methodology; iii) identify challenges and opportunities within RBA; and iv) increase collaboration 30 
internationally. The two-day workshop gathered 28 participants from 16 institutions in 11 countries. It included 31 
technical presentations of RBA methods and case studies, and two break-out sessions for group discussions. All 32 
participants agreed that RBA has substantial potential to inform risk-management decisions in the areas of 33 
food safety, nutrition and public health. Several activities to optimize further developments within RBA were 34 
suggested. This paper provides a summary of workshop presentations, a discussion of challenges that limit 35 
progress in this area, and suggestions of next steps for this promising approach supporting a science-based 36 
decision process in the area of risk-benefit management of foods.  37 
 38 
1. Introduction 39 
1.1. History of RBA of foods 40 
Risk-benefit assessment (RBA) of foods is a relatively new decision-support tool that assesses the combined 41 
beneficial and adverse health effects of consumption of foods in one integrated methodology. It integrates 42 
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knowledge on nutrition, toxicology, microbiology, chemistry and human epidemiology for comprehensive 43 
health impact assessments. RBA is part of the Risk-Benefit Analysis paradigm that combines RBA, risk-benefit 44 
management and risk-benefit communication, similar to the risk analysis paradigm (FAO, 2007). RBA is thus 45 
useful to inform food safety policies or to provide dietary advice based on an integration of the available 46 
scientific knowledge, with the ultimate aim of preventing food-associated diseases and promoting health and 47 
wellbeing of consumers.  48 
 49 
Research to inform public health policies in the area of food and diets has been traditionally focused either on 50 
food safety, i.e. assessing risks and implementing strategies to limit the presence of microbiological or chemical 51 
hazards, or on nutritional assessments, i.e. assessing both risks or benefits of a lack or surplus of foods and 52 
nutrients. RBA is a conceptual and practical shift from the separate assessment of risks or benefits, typically 53 
within toxicology, microbiology and nutrition, to an integrated and multidisciplinary assessment of both risks 54 
and benefits. International organizations such as the World Health Organization (WHO) and Food and 55 
Agriculture Organization (FAO) have conducted RBA of foods to address risk-benefit questions (FAO/WHO, 56 
2008, 2010). In the USA, several RBA studies have been performed on health risks and benefits of seafood 57 
consumption (FDA, 2014; Gochfeld & Burger, 2005; Malden C. Nesheim and Ann L. Yaktine, 2007; Rheinberger 58 
& Hammitt, 2012) Furthermore, the European Food Safety Authority (EFSA) started a discussion on RBA 59 
methodology in 2006, and in 2010 launched a scientific opinion on Guidance on human health risk-benefit 60 
assessment of foods (EFSA, 2006, 2010). Following these initial developments and discussions, important 61 
research and progress within RBA has been performed, for example within European research projects like 62 
BRAFO (Hoekstra et al., 2012), Qalibra (Hart et al., 2013), Beneris (Leino, Karjalainen, & Tuomisto, 2013), and 63 
BEPRARIBEAN (H. Verhagen et al., 2012). In these projects, important steps have been taken to develop RBA 64 
methodology, and first generation software tools were developed to facilitate RBA while taking relevant 65 
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uncertainties into account. In addition, a series of initial case studies was conducted (see e.g. Boobis et al., 66 
2013; Hart et al., 2013; Hoekstra et al., 2012; Hoekstra, Fransen, et al., 2013). These projects were also 67 
important to identify main challenges and limitations of the implementation of RBA at that time. After the 68 
termination of these EU projects, progress in RBA has been made by individual research groups, which have 69 
addressed RBA questions in ad-hoc case studies in response to questions of food safety managers (Anonymous, 70 
2017a; Eneroth, Wallin, Leander, Nilsson Sommar, & Åkesson, 2017; Steffensen et al., 2018) or to make further 71 
progress in RBA method development (Berjia et al., 2014; Boué, 2017).  72 
 73 
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Several of the challenges identified as a result of the European RBA projects (Boobis et al., 2013) still remain, and 74 
include data and knowledge gaps; methodological limitations; difficulties in aggregating/comparing risks and 75 
benefits and in combining human data with data extrapolated from animal studies; lack of harmonization of 76 
concepts; and complexities in communicating RBA results. Furthermore, new research questions and agendas 77 
emphasize a need for assessments that include other societal impacts such as environmental, sustainability and 78 
economic concerns, in addition to public health effects. Tackling these challenges and paving the way for further 79 
development and implementation of RBA requires commitment and contribution of international experts in all 80 
aspects of risk assessment, food safety and nutrition. International collaboration will be crucial for the 81 
establishment and consolidation of RBA as a tool to evaluate scientific evidence to inform decision makers in 82 
public health and food safety at national and international levels. Several research groups in different countries 83 
are committed to further advance the field of RBA of foods, develop methodologies and provide evidence to 84 
support risk-benefit management in food safety and nutrition at national and global level. Leveraging on these 85 
research activities, EFSA sponsored a two-day workshop to gathered international RBA experts to pave the way 86 
forward within the RBA area. This paper describes the structure, contents and overall conclusions of the 87 
workshop. It starts by providing a brief overview of the RBA process and methodology (section 2), describes 88 
examples of current developments of RBA that were presented at the workshop (section 3), as well as the most 89 
important challenges within the field (section 4), and presents the opportunities and suggestions for next steps 90 
within RBA discussed by the experts (section 5).1.2. Workshop objectives and structure 91 
The overall aims of the RBA Workshop were to discuss methods, challenges and needs within RBA and to draft 92 
a roadmap for its future development. The specific objectives were to i) identify RBA activities in Europe and 93 
worldwide; ii) discuss how to further develop and optimize RBA methodology; iii) identify challenges and 94 
opportunities within RBA; and iv) increase collaboration internationally. The two-day workshop gathered 28 95 
participants from 16 institutions in 11 countries in Copenhagen, Denmark, May 2017. Participants and their 96 
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affiliations are presented in the appendix 1.  The workshop included scientific presentations sharing past and 97 
current achievements in the area of RBA; break-out discussion sessions to identify challenges and to discuss 98 
opportunities for further developments in terms of data collection; methodologies and expansion of the scope 99 
of RBA to include other measures of impact; and an overall discussion to plan the future of RBA. 100 
2. Risk-benefit assessment process and methodology 101 
The process of an RBA is similar to the process of a traditional risk assessment. First, the risk-benefit question is 102 
defined by the risk manager, describing the purpose, scope and boundaries of the assessment including at 103 
what level (component, food or diet) the assessment is performed. As part of the problem formulation, the 104 
scenarios to be investigated are defined and the relevant subpopulations are identified. A reference scenario, 105 
which is usually current exposure or consumption, is compared to one or more alternative scenarios. The 106 
alternative scenarios serve to investigate the health impacts of a change in intake, and may be defined based 107 
on for example a worst-case exposure scenario or a recommended intake. Next, the RBA process can be 108 
divided into five steps, where the first four are common to the ones of traditional risk assessments but applied 109 
to risks and benefits separately (Boobis et al., 2013) (Figure 1). Lastly, risks and benefits are integrated to 110 
answer the risk-benefit question. Hence, the RBA process includes i) the identification of adverse and beneficial 111 
health effects associated with the consumption of food(s) and the exposure to food components considered; ii) 112 
the assessment of food consumption or exposure to food components; iii) the characterisation of the relevant 113 
health effects by determining the dose-response relationships for the food components or foods, describing 114 
the association between exposure and likelihood of an effect; and iv) the characterization of risks and benefits 115 
by integrating the information on dose-response relationships and the outcome of the exposure assessment. 116 
The conclusion of the risk-benefit characterization (i.e. step v) can be that a change in intake scenario is 117 
expected to lead to an increase or decrease in the incidence of the studied health effects. This conclusion may 118 
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be based on a qualitative assessment, stating that the health impact of one scenario is beneficial as compared 119 
to another without giving an estimate of the size of the health impact, but it can also be a quantitative 120 
estimate, expressing the health impact in terms of a common health metric such as incidence, mortality, 121 
disability adjusted life years (DALY) or quality adjusted life years (QALY) (Gold, Stevenson, & Fryback, 2002; 122 
Tijhuis et al., 2012). A quantitative assessment may be necessary if one scenario does not clearly stand out 123 
more beneficial or adverse compared to another in the qualitative assessment (Tijhuis et al., 2012); 124 
alternatively the aim of the RBA may be a quantitative outcome from the beginning. 125 
RBA methods have evolved substantially over the years, allowing for improved evaluations of the health impact 126 
of foods. These developments have been equally evident in terms of data collection and analysis, and of 127 
method development and modelling (see 3.). As examples, while the first RBA studies focused on one single 128 
food (e.g. fish) (e.g Hoekstra et al., 2013; Skåre et al., 2015) or one single food component (e.g. folic acid 129 
(Hoekstra et al., 2008)) and investigated risks and benefits in the population as a whole, recent work has taken 130 
into account the health effects of substitution of foods in overall dietary patterns, or variation in the population 131 
in terms of susceptibility or dietary preferences (see 3.2. and 3.3.). The technical session of the workshop 132 
included presentations of past and present RBA case studies illustrating different approaches, some of which 133 
are summarized below. 134 
 135 
3. Current developments in quantitative RBA of foods 136 
3.1. RBA of single foods 137 
The majority of published RBA in the area of food safety and nutrition focused on single foods (Berjia et al., 138 
2014; Eneroth et al., 2017; Hoekstra, Fransen, et al., 2013; Hoekstra, Hart, et al., 2013), with fish being  most 139 
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frequently evaluated (Boué, Guillou, Antignac, Bizec, & Membré, 2015). These RBA studies aimed to assess the 140 
overall impact of a food consumed while considering different levels of exposure and different factors affecting 141 
human health related to the fields of nutrition and/or microbiology and/or toxicology. Although many RBA 142 
performed recognize the broad impact of chemical hazards, nutrients and pathogens, most of them limited the 143 
analysis to only a few. For instance, the first RBA studies addressing fish consumption balanced potential 144 
nutritional benefits with chemical risks without considering potential microbiological effects, whereas another 145 
study on cold smoked salmon considered microbiological risks and nutritional benefits (Berjia et al., 2012). Only 146 
three out of more than 70 RBA studies included microbiological, chemical and nutritional concerns (ANSES, 147 
2013; NAP, 2007; VKM, 2013), but these covered microbiology only with regard to hygiene practices 148 
recommendations.  149 
Until recently, several studies have made efforts to address the challenges of including all potential types of 150 
risks and benefits of foods (Büchner, Hoekstra, & van Rossum, 2007; FAO/WHO, 2006; VKM, 2013), but none of 151 
them were comprehensive by including the three fields of research, nor were they quantitative to enable 152 
estimation of an overall health impact. A recent study that aimed to progress on RBA method development 153 
focused on infant milk consumption during the first months of life, considering breast milk and powdered 154 
infant formula (Boué et al., 2017). Methodological developments were investigated by taking into account a 155 
limited selection of five agents relevant to the case study (Boué et al., 2017). The model was built to quantify 156 
the risk of microbiological and chemical hazards (Cronobacter sakazakii, Cryptosporidium, dioxin like 157 
polychlorinated biphenyls (dl-PCBs) and arsenic), and the benefit of nutrients (docosahexaenoic acid (DHA)) by 158 
taking into account the variability in the population and data and model uncertainty (Boué et al., 2017). In 159 
addition, to progress further on RBA methodological development, variability and uncertainty were studied 160 
separately, using second-order Monte Carlo simulation. 161 
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This study’s individual risk and benefit assessments components (microbiological, nutritional, and chemical) 162 
involved the use of different methods, highlighting the difficulty of using a single harmonized approach. 163 
Likewise, it was not possible to apply one common health metric for all health effects considered. Therefore, 164 
the assessment ended with different output measures (e.g. exposure or DALYs), which hampered the 165 
comparison of all health impacts in a single metric and thus restrained scenarios comparison. To overcome this 166 
limitation, a scoreboard table was suggested, which also facilitated communication of RBA results while 167 
providing a transparent and comprehensive overview. The RBA model developed was the first fully three-168 
disciplinary and quantitative RBA performed for a single food and highlighted that the integration of different 169 
methods and the assessment and communication of variability and uncertainties are still some of the 170 
challenges that have to be tackled.  171 
3.2. Health impact of substitution of foods  172 
Changes in the intake of one food will lead to changes in the consumption of other foods, which will indirectly 173 
affect the overall health impact of the food under study. If the intake of a food product is increased or 174 
decreased, it either leads to a change in overall food intake, or it is compensated by a change of the rest of the 175 
diet. Hence, to obtain a more integrated and realistic assessment of the overall health impact of our diet, it is 176 
essential to consider the whole diet and the potential substitution of foods. Thus far, few studies have 177 
addressed food substitutions in RBA. Van der Voet et al. applied a probabilistic model to assess the health 178 
impact of substituting 10-100% of red meat (beef/pork) with fish in the Dutch diet (van der Voet, de Mul, & van 179 
Klaveren, 2007). The health impact was assessed in terms of probability of exposure being below the tolerable 180 
daily intake (TDI) of hazardous substances (dioxin) and above the adequate intake of beneficial components (n-181 
3 long-chain polyunsaturated fatty acids, DHA and eicosapentaenoic acid (EPA)). By estimating individual 182 
probabilities, this approach allowed the authors to include variability of food consumption between consumers 183 
into the RBA. Hollander et al. 2018 (Hollander, De Jonge, Biesbroek, Hoekstra, & Zijp, 2018) assessed 184 
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qualitatively the health effects of a gram for gram substitution of meat by fish, and Temme et al. 2013 185 
investigated the effects of replacing dairy and meat by plant based products (Temme et al., 2013). 186 
Substitutions on a nutrient level were also assessed as part of the BRAFO project, which included substitution 187 
of saturated fatty acids with mono-unsaturated fatty acids, substitution of saturated fatty acids with 188 
carbohydrates, and substitution of mono- and di-saccharides with low-calorie sweeteners (Hans Verhagen et 189 
al., 2012). However, none of the RBAs reached a quantitative health impact estimate, either due to the lack of 190 
a true risk-benefit question or inconclusive evidence. Others investigated the risk-benefit balance of 191 
substituting added sugar in beverages with artificial sweeteners, in terms of either risk of exceeding established 192 
reference doses (Husøy et al., 2008) or body mass index (BMI) (Hendriksen, Tijhuis, Fransen, Verhagen, & 193 
Hoekstra, 2011). 194 
Current work at DTU Food investigates the health impact of changing from the current Danish diet to a diet 195 
that follows the Danish National Dietary Guidelines (Thomsen et al., 2018). The approach weighs nutritional 196 
benefits against nutritional and toxicological risks, and accounts for the substitution of foods. The model is 197 
based on a case study on substitution of red and processed meat with fish in the Danish adult diet. In this case 198 
study, the observed individual mean daily fish intakes for all adult individuals (> 15 years) in the Danish 199 
National Survey of Diet and Physical Activity are increased to 50 g/day as recommended in the guidelines (350 200 
g/week). Using pre-defined substitution factors that take portion sizes and meal-specific differences into 201 
account, a corresponding decrease in the intake of red and processed meat was modelled. Four substitution 202 
scenarios addressing the impact of varying chemical and nutrient exposures on the final health impact were 203 
investigated and the net health gain or loss of the substitutions was measured in DALYs. Other foods could 204 
potentially be added to the model to reflect a more realistic substitution and the whole diet. The approach may 205 
account for changes in energy intake associated with substitutions, as well as the health impact of these 206 
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changes. To our knowledge, this is the first quantitative RBA that uses DALYs as health metric whilst taking 207 
substitution of foods into account.  208 
3.3. Optimization of personalized dietary recommendations 209 
Even though official dietary guidelines are developed to motivate the population to follow healthy food 210 
consumption patterns, repeated national surveys have shown that most individuals do not meet the intakes 211 
recommended by the food and health authorities (Pedersen et al., 2010; Tetens et al., 2013). To investigate 212 
how to inform dietary advice that has a higher adherence by individuals, recent studies have applied 213 
mathematical optimization techniques to propose personalized intake recommendations (Maillot et al., 2009; 214 
Maillot, Vieux, Amiot, & Darmon, 2010; Persson et al., 2018). Personalized recommendations may be perceived 215 
as more relevant, because they can account for individual preference, needs, and beliefs (Brug, Campbell, & 216 
van Assema, 1999).  217 
In a case-study on consumption of fish in the Danish adult population, quadratic programming models were 218 
applied to generate personalized fish intake recommendations fulfilling pre-defined criteria in terms of intake 219 
recommendations for EPA, DHA, and vitamin D and tolerable intake levels for methyl mercury, dioxins, and dl-220 
PCBs, while simultaneously deviating as little as possible from observed individual intakes (Persson et al., 221 
2018). Such an approach has the potential to increase compliance with dietary guidelines by targeting the 222 
individual consumers and minimizing the need for large and potentially unrealistic changes in consumption 223 
patterns. The output is a range of intakes for different fish species that can be proposed as a personalized 224 
recommendation for each individual in the population.  225 
The approach of optimization of a single food recommendation can be improved by taking into account 226 
individual exposures to nutrients and contaminants from other sources than the food of interest, which enable 227 
refined minimum and maximum exposure criteria. The approach can also be used to optimize whole diets 228 
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(Barre et al., 2016; Maillot et al., 2009, 2010). Environmental or other specific individual background exposures 229 
may still require consideration in both cases. Current research at DTU Food analyses the impact of individual 230 
exposures due to foods other than fish, dietary supplements and the environment, by expanding the case study 231 
of fish intake in Denmark (Persson et al., 2018) with individual data on this background exposure. Lastly, the 232 
optimization approach can be expanded to include other food-related issues beyond public health, such as 233 
sustainability (Horgan, Perrin, Whybrow, & Macdiarmid, 2016; Kramer, Tyszler, Veer, & Blonk, 2017), economic 234 
impact (Darmon, Ferguson, & Briend, 2002; Maillot, Vieux, Delaere, Lluch, & Darmon, 2017) or both (Van 235 
Dooren, Tyszler, Kramer, & Aiking, 2015) 236 
4. Current challenges within RBA 237 
Although significant progress has been made in the development of RBA, several challenges remain (Maarten J. 238 
Nauta et al., 2018). RBA has to face challenges of traditional risk assessment in the different disciplines, which 239 
are not specific for RBA, i.e. challenges related to data availability, variability between groups of consumers and 240 
individuals, strength of evidence and uncertainty in the dose response. In addition, there are challenges in 241 
defining how uncertainties should be presented to policymakers and the general public, and what guidance can 242 
be given to help policymakers make decisions based on uncertain evidence. Because of the parallel streams 243 
assessing adverse and beneficial impacts of foods or components, RBA faces additional challenges, including 244 
the integration of diverse data sources (e.g. from experimental animal studies and human epidemiological 245 
studies); heterogeneity of information between risks and benefits, classification of approaches for different 246 
types of risk-benefit questions (i.e. focusing on foods, food components or diets); scenario development 247 
including relevant policy options; and selection of metrics to evaluate and compare risks and benefits.  Lastly, 248 
there are also challenges related to the current need to incorporate more than just health risks and benefits 249 
(e.g.: sustainability and economic consequences) to allow policymakers to make better informed decisions, and 250 
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the consequent requirement to further develop methodologies and approaches to perform those “expanded 251 
RBA”. During the workshop, two categories of challenges were discussed in working groups, those related to 252 
“health RBA” and those specific to “expanded RBA”.  253 
4.1. Challenges related to RBA of health impact of foods 254 
Aligning the Risk-Benefit question and the methodological approaches 255 
The formulation of a risk-benefit question precedes the RBA and is of crucial importance to ensure that the 256 
RBA is focused, fit for purpose, and well-structured (Boobis et al., 2013; Hoekstra et al., 2012). The risk-benefit 257 
question will guide the choice of the RBA methodology and also the choice of risk-benefit metric. It is usually 258 
the risk-benefit manager that asks the RBA question, refined as necessary in dialogue with the risk-benefit 259 
assessors. Risk-benefit managers may be regulatory agencies such as national governments. However, policy 260 
makers with focus in the various aspects of food are often scattered in different regulatory bodies, with distinct 261 
interests, areas of action and potentially RBA questions. In addition, food companies and consumers may also 262 
have the “risk-benefit manager role” and will have different interests for such assessments. As an example, 263 
regulatory bodies may be primarily interested in defining safety criteria, priority setting and public health, 264 
whereas consumers may have more interest in their personal dietary choices and the anticipated health 265 
impacts of these choices. Hence, a broad range of risk-benefit questions and objectives are possible. For 266 
example, RBA may want to consider different levels of aggregation (e.g. a food component, food product or the 267 
whole diet), or the objective may be to compare specific scenarios and/or sub-populations to assess if the risk 268 
exceeds the benefit or vice versa (Hans Verhagen et al., 2012). The goal may also be to identify the most 269 
advantageous intake scenario (Berjia et al., 2014), or to provide a quantitative estimate of the overall health 270 
impact. RBA can include only health effects or be “expanded” to include non-health factors such as economy, 271 
sustainability and consumer preference (Ocké MC, Toxopeus IB, Geurts M, Mengelers MJB, Temme EHM, 2017; 272 
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Juliana M. Ruzante, Grieger, Woodward, Lambertini, & Kowalcyk, 2017; Seves et al., 2016; Temme et al., 2013; 273 
van de Kamp, Seves, & Temme, 2018). 274 
Development of guidance on the approaches that can be adopted for different types of risk-benefit questions 275 
would facilitate the framing and the performance of RBA, and would support methodological harmonization in 276 
the future. Depending on the type of question, such guidance could for example assist in the selection of food 277 
components and foods as well as the health effects to be included in the RBA, and point out when quantitative 278 
approaches are needed. In general, clear and continuous communication between risk-benefit assessors and 279 
risk-benefit managers about the risk-benefit question and the methodological approach of choice is of crucial 280 
importance to ensure fit for purpose RBA.  281 
Variability between groups of consumers and individuals 282 
The inherent differences between individuals may lead to the risks and benefits differing between individuals 283 
and certain subpopulations (e.g. children, pregnant women, elderly). If this variability is ignored in RBA, certain 284 
(groups of) vulnerable individuals suffering from higher health risks may be ignored in its conclusions, even if 285 
an intake scenario, on average, is beneficial for the population. However, inclusion of variability demands 286 
knowledge on potential differences in health effects between groups of consumers and individuals, and this 287 
knowledge may not be available. Also, it increases the complexity of the RBA. 288 
Variability  is for example a concern for decisions on fortification, such as folic acid fortification of bread and 289 
iodine fortification of salt. This fortification may be considered beneficial for the majority of the population, or 290 
beneficial as expressed by overall population health gain, but may have negative health effects for subgroups 291 
(Hoekstra et al., 2008). Food policies such as fortification may lead to (health) winners and losers and it is an 292 
ethical political question whether such a policy should be implemented. However, it is the responsibility of the 293 
risk-benefit assessor to inform the policy maker of the effects on different subpopulations. Due to this different 294 
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susceptibility among the population groups, the application of folic acid fortification is still debated (Eckner, 295 
Bjørn, Lunestad, & Rosnes, 2014). Taking the variability into account is crucial in RBA and can reveal population 296 
groups that are at high risk or that will gain large benefit. It enables evaluation of the effect of specific 297 
interventions (i.e. assessing which groups gain the largest benefit and which population group might 298 
experience a health loss due to the intervention), thus enabling better informed policy decisions (Hart et al., 299 
2013; Hoekstra, Hart, et al., 2013). 300 
There are different levels at which the variability can be assessed in RBA. First, the entire distribution of 301 
exposures within the population can be used instead of a mean exposure estimate (Hart et al., 2013). This has 302 
been addressed by different methods in previous RBAs (Hart et al., 2013; Hoekstra, Hart, et al., 2013; van der 303 
Voet et al., 2007). Second, if detailed population statistics are available, variability between sub-population 304 
groups can also be taken into account explicitly. In such cases, RBAs are performed for each sub-population 305 
group and results are compared.  306 
Risk-Benefit comparison metrics 307 
There are several health metrics that can be used in RBA. Fransen et al (2010) divided risk-benefit comparison 308 
metrics into three categories: single outcome (e.g.: disease incidence, mortality); integrated (or summary) 309 
health (e.g.: DALY and QALY); and economically oriented measures such as WTP (willingness to pay). The choice 310 
of metric will depend on the type of question being asked by the risk-benefit manager and the complexity of 311 
the evaluation being done. For instance, in a situation where different components affect the same endpoint in 312 
an individual both positively and negatively, a net effect for the health outcome can be calculated, and 313 
integrated measures might not be needed  (Fransen et al., 2010; Zeilmaker et al., 2013b). However, it is often 314 
the case that risk-benefit questions are more complex and involve multiple health effects, including different 315 
health effects for hazards and benefits, and therefore summary population measures such as disability 316 
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adjusted life year (DALY) can be helpful. For this reason, we focused our discussions during the workshop on 317 
the use and challenges associated with integrated measures, more specifically DALY.  318 
In recent years, the DALY has been frequently used in quantitative RBA as it is able to aggregate both mortality 319 
and morbidity measures associated with several health outcomes (Murray, 1994). It is the metric of choice for 320 
the Global Burden of Disease studies (Anonymous, 2017b), and has been shown to be a valuable instrument for 321 
risk ranking of foodborne hazards (Havelaar et al., 2012, 2015). It has also been  applied in RBA studies to 322 
summarize the overall health impacts of foods (Berjia et al., 2014; Eneroth et al., 2017; Hoekstra, Fransen, et 323 
al., 2013; Hoekstra, Hart, et al., 2013). While a single DALY estimate is usually the final estimate in burden of 324 
disease studies, the difference in DALYs between a reference and an alternative scenario (∆DALY) has been 325 
used as the final estimate of RBA studies (Eneroth et al., 2017; Firew Berjia, Andersen, Hoekstra, Poulsen, & 326 
Nauta, 2012).  327 
Several limitations of the DALY have been identified, both in terms of how the metric is communicated and 328 
perceived, and in the assumptions behind the method. Underlying the DALY metric is the idea that many 329 
people suffering from a mild disease is as bad as few people suffering from a severe disease. The DALY provides 330 
an expected value for the population and does not clearly reflect the two dimensions used for its calculation: 331 
the probability of effect for individuals in the population and the severity of these effects. As an illustration, 332 
consider a population of 100,000 people with a remaining life expectancy of 20 years, where all individuals get 333 
infected by a pathogen. If the single effect of this infection is a probability of immediate death of one in a 334 
million (0.0001%), this yields a loss of 100,000 * 0.000001 * 20 = 2 DALYs. If the single effect is that 10% of the 335 
people get 1 day of mild diarrhea, with severity weight 0.074 (Salomon et al 2015), this also yields a loss of 336 
100,000*1/365*0.074*0.1 = 2 DALYs. Despite the same DALY estimation, the two scenarios are clearly 337 
different: in the first case, it is most likely that none of the 100,000 people involved will suffer from anything; in 338 
the second case, 10% of the people get ill, so around 10,000 people will be affected. If risk managers are only 339 
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informed about the 2 DALY and not about this difference (about 10,000 ill people versus maybe one death), 340 
they may base their decisions on incomplete information. Hence, the advantage of an integrated metric, i.e. 341 
that it summarizes complex issues into one figure allowing direct comparison of multiple risks and benefits, 342 
may also be a disadvantage if improperly used or misinterpreted. Care should therefore always be given to 343 
presenting all of the relevant underlying information (such as the basic assumptions and estimates of 344 
incidence, mortality and attending uncertainty) to the decision makers. Likewise, because multiple health 345 
outcomes may be considered in the total DALY estimate, the impact on the net health of one subgroup may be 346 
clearly greater than for another subgroup in the population. Again, an example would be folic acid fortification 347 
in which one group benefits whereas another group experiences the risks (Hoekstra et al. 2008). 348 
Quality adjusted life years (QALY) were not the focus of the discussions, but have also been used as integrated 349 
measures in RBA (EFSA, 2006; Ponce et al., 2000). QALY has similar advantages and disadvantages as the DALY 350 
and is also part of the Qalibra software tool (Hart et al., 2013). 351 
The strength of evidence and uncertainty  352 
Weighing and integrating evidence represents a substantial challenge because RBA involves various individual 353 
risks and benefits assessments, for which the current scientific strength of evidence might be different (Dorne 354 
et al., 2016). Consequently, evidence for each health is collected from different types of studies (e.g. 355 
epidemiological and toxicological studies). To date, all lines of evidence considered in RBA are reported only 356 
qualitatively, as advised by the EFSA guidance on RBA and the BRAFO approach (EFSA, 2010; Hoekstra et al., 357 
2012). This qualitative integration does not allow for integrating the strength of evidence in the final output of 358 
quantitative RBA (e.g. DALY), which introduces an additional source of uncertainty.  359 
The criteria for minimum weight of evidence are different in toxicology and nutrition. In general, the evidence 360 
accepted to refer to a toxicological hazard as “hazard” may be much weaker than the evidence needed to refer 361 
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to a benefit as “benefit”. In risk assessment, it is likely that a precautionary approach will be applied if there are 362 
indications of a potential risk, even if the evidence is weak (Boobis et al., 2013; Hoekstra, Hart, et al., 2013; M.J. 363 
Nauta et al., 2018; Tijhuis et al., 2012). In contrast, claims for beneficial or adverse health effects of a food or 364 
nutrient need to be supported by convincing scientific evidence before they are acknowledged (Boobis et al., 365 
2013). If the established criteria for inclusion of adverse and beneficial health effects are used, toxicological 366 
risks with a low level of evidence may be more likely to be included than nutritional benefits with the same low 367 
level of evidence., This may lead to a skewed RBA. For example, the relative risk of colorectal cancer from 368 
folate supplements is around 1, with an upper 95% confidence interval of around 1.2, but as high as 1.7 is some 369 
studies (see (SACN, 2017)). The relative risk of a neural tube affected pregnancy is 0.29 after folic acid 370 
supplements, with 95% CI of 0.12-0.71 (MRC Vitamine Study Research Group, 1991), An approach to assess an 371 
upper bound risk of up to 77% increased incidence from a non-significant risk against a significant benefit of a 372 
70% reduction, on average, in NTDs is still not available. This is clearly an area of RBA that needs further 373 
development, such that risks and benefits can be weighted in some way for the respective levels of evidence 374 
 375 
The characterization of the risks and benefits (i.e. the estimated health impact) is not necessarily affected by 376 
this discrepancy, unless uncertainty factors that address the high uncertainty for low level evidence effects are 377 
included in the dose response. However, if effects with a low level of evidence i.e. high uncertainty of 378 
occurring, but potentially high health impact are ignored, the assessment could give a misleading suggestion.  379 
Therefore, in communication with policymakers or risk managers, it is important to clearly address the 380 
intentions of the RBA, and carefully demonstrate the assumptions in the inclusion and exclusion criteria of 381 
adverse and positive health effects and their level of evidence. RBA should not be misused to play down health 382 
risks associated with foods, nor should it overemphasize or ignore potential health benefits. This implies again 383 
that transparency is of crucial importance for RBA, and that communication is an essential component of the 384 
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RBA process. Ultimately, it is the RBA manager that is responsible for the policy decision, and to support this 385 
decision, it is the role of the RBA assessor to provide all relevant information, including an assessment of the 386 
uncertainties, in as clear and transparent manner as possible, to support this. 387 
Within RBA, strength of evidence is closely connected to the uncertainty assessment, which expresses the 388 
belief in the obtained results. Uncertainties are propagated for example via the derived dose-response models 389 
to the final DALY estimate and may, if not quantified, lead to misleading conclusions (Benford et al., 2018). This 390 
stresses the need for quantification, or at least a qualitative assessment, of uncertainties in RBA (Hart et al., 391 
2013). For RBA, the EU project Qalibra has developed a tool to include uncertainty in stochastic quantitative 392 
models (Hart et al., 2013). The methodology of uncertainty assessment is still in development, it is not specific 393 
to RBA but inherent to any science-based decision: the lack of knowledge generates imprecision in the results. 394 
The impact of this imprecision has to be assessed before making decision. Sensitivity analysis is a powerful 395 
technique to assess this impact (Saltelli, 2002). In particular, it helps prioritizing additional data collection or 396 
research. However, when quantification is not possible, reporting a qualitative expression of uncertainty is still 397 
important as advised in the BRAFO tiered approach (Hoekstra et al., 2012) and illustrated in (Hoekstra, Hart, et 398 
al., 2013) and (Boué, 2017).  399 
Uncertainty in the dose response 400 
One of the major sources of uncertainty in RBA is the relationship between intake of a food or food component 401 
and a health effect. The ideal scientific studies to establish causality between exposure to a component and a 402 
health effect are randomized control trials with human participants. However, these are often not feasible for 403 
ethical and/or economic reasons. Other types of studies, such as (human or animal) observational studies that 404 
may reveal associations between intake of food components, contaminants, foods and diets and the likelihood 405 
of a health effect, may be used alternatively. Systematic reviews and meta-analyses of all available 406 
epidemiological evidence (e.g. derived by longitudinal cohort studies), which are suitable for ensuring a higher 407 
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level of evidence compared to using single studies available, are commonly used to describe the change in risk 408 
of health effects associated with dietary patterns and chronic exposure to chemicals (e.g. (Aune et al., 2015; 409 
Aune, Ursin, & Veierød, 2009; Hoekstra, Hart, et al., 2013)). Data from animal studies may be used to establish 410 
dose-response relations for chemical hazards, preferably supported by epidemiological studies. 411 
For establishing the dose response relation, different types of evidence may be used in toxicology, 412 
microbiology and nutrition. Specifically in microbiological risk assessment, animal experiments are often not 413 
informative to establish a dose response relation, because the response to exposure to human pathogens is 414 
not comparable between humans and animals. The evidence often originates from either experimental studies 415 
with human volunteers, usually healthy young people that are not representative for the whole population 416 
(Teunis, Nagelkerke, & Haas, 1999), or outbreak studies that typically involve the more virulent strains or more 417 
vulnerable people (Teunis et al., 2010). In nutrition, whilst some data may be available from controlled clinical 418 
studies, more often reliance is on observational human epidemiological studies, which demand advanced 419 
statistical analysis, and interaction and confounding plays an important role: as only association can be studied, 420 
the evidence for causal relations may be weak (Tijhuis et al., 2012). In toxicological risk assessment, 421 
extrapolation/uncertainty factors are used to account for intra-species differences, and interspecies differences 422 
when translating observations from animal experiments into anticipated human health effects (van der Voet & 423 
Slob, 2007). . Another challenge is that adverse effects observed in animal studies may not be easily translated 424 
into human disease. Similarly, extracting the time of onset of a disease can be difficult, often requiring 425 
debatable assumptions. Examples of how in some cases exposure to chemicals is converted in DALYs can be 426 
found in (Gibb et al., 2015; Hoekstra, Hart, et al., 2013; Zeilmaker et al., 2013a).  427 
The difference in methods for deriving dose response relations in RBA may be associated with different biases 428 
and systematic errors, and the attending uncertainties are of a different nature. Within a research discipline, 429 
these biases and errors may be relatively unimportant when risks or benefits that are derived by the same 430 
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methods are compared. But in RBA these differences may have a large impact on the output of the RBA. 431 
Currently, no established methods are available to overcome these differences. Performing a sensitivity 432 
analysis to highlight which sources contribute more to the overall uncertainty is recommended. 433 
 434 
Data availability  435 
The availability and quality of data is a common challenge in RBA, just as it is in traditional nutrition and risk 436 
assessments. Previous reviews have identified a number of data needs and general challenges, and most of 437 
these still remain (Boobis et al., 2013; EFSA, 2010; Maarten J. Nauta et al., 2018). There are different types of 438 
data to consider: data on food consumption, levels of nutrients and contaminants in foods, microbial 439 
contamination of food, background data on human disease (e.g. incidence, disability weights, pattern of 440 
disease progression), and dose-responses relationships. Food consumption data may be available from national 441 
dietary food surveys, which have been expanded and improved continuously (e.g. (ANSES, 2017; Pedersen et 442 
al., 2010)), but it may be difficult to compare them between countries, due to differences in their design. 443 
Regional databases such as the EFSA Comprehensive Food Consumption Database and harmonization guidance 444 
(e.g. the EFSA’s general principles for the collection of national food consumption data in the view of a pan-445 
European dietary survey, known as the EU Menu) are a valuable resource to overcome these limitations and 446 
ensure comparability (EFSA, 2011, 2014b). National food databases usually include information on nutrient 447 
content of foods, but national monitoring data on the concentration of contaminants in foods may not be 448 
available. Data from which dose-response relationships can be constructed are crucial to enable risks and 449 
benefits to be estimated quantitatively. The type of data and source of information greatly differ between 450 
microbiology, toxicology, nutrition, and epidemiology; and between foods, food components, and 451 
contaminants. If using an integrated metric such as the DALY to compare risks and benefits, data on life 452 
expectancy, disability weights and duration associated with the different health effects are needed 453 
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(Devleesschauwer et al., 2014; Hart et al., 2013). These data are specific to the sub-population of interest but 454 
rarely available at the national level. In addition, even though substantial amounts of data were published, 455 
these may be available in different formats or not directly suitable for use in RBA. Increased efforts to establish 456 
available, transparent and easily accessible database(s), with suitable contextual information i.e. the metadata, 457 
are needed to fill these data gaps for RBA. If observational or experimental data are lacking, another option is 458 
to gather information through expert elicitation (Cooke, 1991; EFSA, 2014a; EPA, 2009). This technique is 459 
already used in microbial risk assessment  (Albert et al., 2012; Pujol, Johnson, Magras, Albert, & Membré, 2015; 460 
Van der Fels-Klerx, Cooke, Nauta, Goossens, & Havelaar, 2005) and more generally in food safety (Hald et al., 461 
2016). 462 
 463 
4.2. Challenges related to RBA including non-health related impact  464 
RBA research has so far built on the principles of risk analysis for food safety, where the end-point is the human 465 
health impact of food intake scenarios. However, decision makers must take into consideration factors other 466 
than human health when making policy decisions (FAO/WHO, 2011; FAO, 2017). Thus, what the risk benefit 467 
manager needs is a comprehensive understanding and a way to consider and balance the health impacts of 468 
changes in food intake with effects on other factors such as sustainability, consumer preferences, the 469 
economy, and societal values. For clarity, the question whether other disciplines should be included in the RBA 470 
must be included in the risk-benefit question. Often, this question is in line with the general interests of 471 
society, e.g. discuss how risk and benefits are balanced in other disciplines, including pharmaceutical drugs (H. 472 
Verhagen et al., 2012) . There is consensus that, in the longer-term, RBA based only on health will not be 473 
sufficient to address risk management and societal questions, and including non-health factors is inevitable and 474 
necessary. This need is not unique to RBA and has been thoroughly discussed in different food-related policy 475 
areas such as food safety, agriculture, the environment and nutrition (Anonymous, 2018; FAO, 2017). Clear 476 
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priorities need to be identified at national and international levels in order to make best use of finite resources, 477 
and to ensure that decisions to ensure food safety do not negatively impact on other dimensions essential for 478 
development, e.g. trade, economics, food security, tourism, social well-being (FAO, 2017). An integrated 479 
approach requires an interdisciplinary procedure as well as exchange of data from the different disciplines 480 
involved. Bringing together data on safety (e.g. contamination), health aspects (e.g. nutrient composition), 481 
sustainability indicators (e.g. land use) and other characteristics (such as price) concerning the same products is 482 
important in order to facilitate interdisciplinary research. However, adding such factors makes the analysis 483 
more complex, potentially less transparent and harder to be updated as new data becomes available. Also, it 484 
increases the number of stakeholders involved, and requires a methodology in which those effects can be 485 
transparently weighted and compared. Multi-criteria decision analysis (MCDA) has been designed to address 486 
such complex decision problems, while making the analysis transparent and systematic. MCDA has been used 487 
in innumerous fields from emerging technologies (Bates et al., 2016) to establishing priorities for foodborne 488 
illness (Juliana Martins Ruzante et al., 2010). It is a robust decision analysis tool that integrates different factors 489 
(i.e. criteria), while considering the preference and values of policy makers as well as stakeholders (FAO, 2017). 490 
MCDA has been used to balance risk and benefits of pharmaceutical drugs (Hsu, Tang, & Lu, 2015; Tervonen, 491 
van Valkenhoef, Buskens, Hillege, & Postmus, 2011), emerging technologies (Tsang, Bates, Madison, & Linkov, 492 
2014), and just recently a framework was proposed describing how it could be applied to foods (Juliana M. 493 
Ruzante et al., 2017).  The challenges associated with incorporating other factors relevant to policy decision 494 
besides the typical RBA will not be related directly to the application of MCDA, but rather with the different 495 
magnitudes of uncertainty and the data availability to characterize those other factors. The field of medical 496 
products and drug development is more advanced in this area than food and nutrition, and has guidelines to 497 
gather and incorporate patient’s perspective into their RBA analysis of future drugs (FDA, 2013; Nixon et al., 498 
2016), which can be used as an example for RBA of foods.  499 
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At the workshop, sustainability was mentioned as being on the shortlist of aspects to include in the RBA. 500 
However, sustainability is not easily quantified by a single indicator. Several indicators in the area of food exist, 501 
such as greenhouse gas emission, water use, biodiversity, and others (Agovino, Cerciello, & Gatto, 2018; 502 
Chaudhary, Gustafson, & Mathys, 2018; Dora et al., 2015; Hallström, Carlsson-Kanyama, & Börjesson, 2015; 503 
Horgan, Perrin, Whybrow, & Macdiarmid, 2016; van Wagenberg et al., 2017). The choice for the most suitable 504 
indicator and/or weighing between them must be made depending on the assessment. Economic factors and 505 
consumer preferences were mentioned as other aspects that are important in a food policy assessment. 506 
Sustainability factors have been incorporated in some studies (e.g. (Donati et al., 2016; Masset, Soler, Vieux, & 507 
Darmon, 2014)). In another example, Temme et al. 2013 investigated the health and sustainability effects if 508 
meat and dairy were to be replaced by plant derived foods. Health effects were expressed as saturated fatty 509 
acid (SFA) and iron (Fe) intake in women, and sustainability was expressed as land use. An integrative metric 510 
was not necessary as all indicators pointed in the same direction: replacement of meat and dairy foods by 511 
plant-based foods reduced land use for food consumption, and SFA intake of young females and did not 512 
compromise total Fe intake. Seves et al. 2015 examined the health and sustainability effects of the 513 
consumption of different fish species. Sustainability was measured by land use (by fish farms) and greenhouse 514 
gas emission, and having a sustainability label which was partly a measure for overfishing. The health benefits 515 
were expressed by the EPA and DHA (fish oil) content of the fish species. The study concluded that herring and 516 
salmon (cultivate and wild-caught with ASC/MSC logo) are species favorable in terms of beneficial for health 517 
and the environment. In 2017, RIVM published a large study involving the current and future Dutch diet (Ocké 518 
MC, Toxopeus IB, Geurts M, Mengelers MJB, Temme EHM, 2017) that attempted to disentangle and analyze 519 
the integrated complexity of safe, healthy and sustainable diets. It analyzes the population’s diet according to 520 
microbial and chemical safety, nutritious value, cost, consumer preference, future trends in production, and 521 
sustainability factors. Ocké et al. (2017) discovered that the trio of safety, health and sustainability is not 522 
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enough when it comes to the actual behavioral motives related to food. Consumer motives like convenience, 523 
enjoyment and cost, as well as prosperity motives like employment and export and ethical issues like animal 524 
welfare are also involved. These are all issues that carry weight individually and in society. The report is 525 
concentrated on safe, healthy and sustainable diets without disregarding these other motives. Three extreme 526 
scenarios were developed qualitatively, focusing on safety, health or sustainability.  The scenarios were 527 
analyzed and scored by exerts with a systematic group decision-support method. An attempt was made to use 528 
an MCDA method  to weigh different scenarios (Ocké MC, Toxopeus IB, Geurts M, Mengelers MJB, Temme 529 
EHM, 2017; Saaty, 1994). Although the method proved promising, due to the uncertainties in quantifying 530 
underlying sub-criteria of indicators for sustainability, food safety and health, it was not possible to make the 531 
(subjective) weighing of the different aspects transparent and the final outcome was not used. Nevertheless, 532 
using expert-judgement and semi-quantification, the report concludes that opportunities to combine safety, 533 
health and ecological sustainability in an integrated food policy exist. 534 
 535 
4.3. Communication of RBA results 536 
The area of risk communication has been growing and has made great progress in better understanding 537 
consumer behavior, and how risk is perceived (Frewer et al., 2016). Despite remaining challenges and 538 
limitations, stakeholders are now better equipped to communicate risks to consumers. Under the risk-analysis 539 
paradigm, risk assessors have also made progress in communicating with risk managers and other stakeholders 540 
before, during and after a risk assessment is conducted and results are published. In most areas there is a 541 
demand for decisions to be transparent, and engaging with stakeholders early-on is key. 542 
Communicating RBA messages is more complex than communicating risks or benefits separately. On one hand, 543 
the way risk is perceived is very different of how benefit is perceived by consumers. On the other hand, 544 
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because the overall process incorporates (at least) those two components’ analyses, and their integration, the 545 
data, the uncertainty around it and the assumptions are more difficult to be described, which could potentially 546 
add confusion. It is important to understand the target population and establish trust by working in close 547 
collaboration with stakeholders and social scientists specialized in risk communication. More research is 548 
needed to understand consumer’s trade-offs and values when it comes to risk and benefits of foods. Rideout 549 
and Kosatsky (2017) argue that also other factors than risks and benefits associated with physical health should 550 
be assessed when developing advice for specific populations (Rideout & Kosatsky, 2017). They suggest other 551 
factors to weigh in addition to health risks and benefits, such as socioeconomic and sociocultural factors, and 552 
to apply e.g. health impact assessment to evaluate external impacts of a consumption advice or policy (such as 553 
substitution of foods), and other qualitative tools for development of more comprehensive and effective 554 
advice. 555 
In addition, it is crucial that the results and methods of RBA studies are transparent and that uncertainty, when 556 
possible, is taken into account and reported with the results. Likewise, it is important that the level of evidence 557 
for all effects is considered, and that the limitations in available data and assumptions made are communicated 558 
with the results. Especially when RBA studies are made for methodology development purposes, particular 559 
care should be taken in how any preliminary results are communicated, if they do not reflect a definitive RBA. 560 
Moving towards an optimal communication of RBA results to all stakeholders requires a closer collaboration 561 
with social scientists. While these needs were considered and emphasized at the workshop, communication 562 
tools were not the scope of the discussions.   563 
5.  Opportunities and way forward 564 
As a last step, the participants of the workshop discussed the practical way forward to take RBA to the next 565 
stage. Building on the challenges and opportunities identified, a number of needs and practical suggestions 566 
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were presented. In addition, activities that promote collaboration and integration of research efforts were put 567 
on the agenda for a RBA Network formally launched at the event. 568 
It was generally agreed that the discussions on needs, methods and challenges should now be followed by the 569 
development of case studies, in which the identified challenges are addressed. Two options were identified: to 570 
develop new cases using the tools and frameworks that are now available; to re-open cases that have been 571 
performed previously, and apply new data and new methods to test the improvements that can be made and 572 
to evaluate their robustness. Examples include probabilistic approaches that allow for the assessment of 573 
variability and uncertainty and models that take substitution of foods into account. These case studies can also 574 
be applied to compare different health metrics (in parallel to the DALY). The latter should preferably be 575 
followed by research on the perception and communication of these different metrics to different 576 
stakeholders. 577 
A categorization of RBA studies will be advantageous, for example by comparing the level of aggregation of the 578 
RBA (on food components, foods or diet), the risk-benefit question (which scenarios are to be compared, which 579 
consumer groups are included, what food components and contaminants associated with potential health 580 
effects are included), whether there is a need for a quantitative and/or stochastic approach, etc. (see section 581 
Aligning Risk-Benefit question and methodological approaches, section 4.1.). Ideally, these case studies would 582 
be performed by different research groups, and a platform to share and discuss their assessments should be 583 
created.   584 
Another generally recognized challenge within RBA is the availability of data (section 4.1). To harmonize RBA 585 
internationally and to facilitate the application of RBA by national and international risk and benefit managers, 586 
it is important to establish and maintain shared databases with dietary intake data, concentration data on 587 
nutrients and contaminants, dose response data, data from observational studies and health data. These 588 
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databases should be transparent and easily accessible, and setting up and maintaining such a database(s) 589 
would be a community effort that requires broad international support.  590 
In Europe, EFSA might expand its role as curator of such databases. RBA research groups should provide input 591 
to EFSA and other data providers on data needs. Furthermore, EFSA is already taking initiative to lead 592 
discussions on current challenges of the integration of evidence with very diverse and not readily comparable 593 
underlying evidence bases, and motivate stakeholders to address them (EFSA, 2018). Again, this should be a 594 
collaborative effort with broad international support.  595 
As the challenges associated to RBA are complex, expertise required are numerous and the data needs are 596 
large, the workshop participants concluded that intensive international collaboration is a prerequisite for the 597 
development of this novel discipline. Formalizing an RBA international network will facilitate all future activities 598 
discussed and proposed in the workshop, and will help partners in consolidating and further developing current 599 
activities. Ideally, such a platform should be formed within a European or global international project, to 600 
ensure that harmonized approaches can be developed, and that these build on consensus in the international 601 
scientific community and can serve as a basis for global decision making. Due to the unique multidisciplinary 602 
character of RBA, it may be challenging to identify scientific associations and funding bodies that cover all its 603 
scientific and societal aspects. Still, networking initiatives can be established, for example via research 604 
applications and, at international level, with symposia organized at scientific conferences. With this in mind, 605 
participants have decided to launch the International Network for Risk-Benefit Assessment of Foods. The 606 
network is to be chaired by DTU Food and will be open to any group or individual with an active interest in the 607 
area. Among other overall goals, this network will serve as a forum for continuation of the discussions here 608 
described. 609 
Overall, the workshop participants agreed that RBA is a promising and highly relevant research area that 610 
deserves increased attention worldwide. Because the broad range of public-health activities associated with 611 
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foods and diets brings a high degree of complexity to policy development and a need to involve various 612 
stakeholders to ensure synergy, international bodies such as the FAO have stressed that ‘policy coherence’ 613 
across ministries is key (FAO, 2017). RBA approaches, particularly when expanded to include non-health related 614 
impacts, can be a powerful tool to assist risk-managers defining policy that achieves the best societal 615 
outcomes. 616 
RBA ultimately may show how integration of a variety of scientific disciplines and approaches can be used to 617 
address specific and general policy questions, and serve governmental regulatory bodies, food industry and 618 
individual consumers alike. 619 
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